ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.

85,013 comparisons

Most participants first33,758 with no events in either group come last181 to 200 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Anesthesia Control Tower Monitoring vs Standard of Care Arm: Measured Anesthetic Concentration30,087 of 30,460

29,851 of 30,175

-0.2 points

-0.3 to 0.0

60,635NCT03923699

Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety

Cases vs Controls: Number of Participants BMI ≥30 With Diagnosis of Venous Thromboembolism After the Start of Follow-up for Each Person685 of 23,725

760 of 36,835

0.8 points

0.6 to 1.1

60,560NCT04969653

The Incidence of Venous Thromboembolism in Atopic Dermatitis

People With Ulcerative Colitis (Cases) vs People Without Ulcerative Colitis (Controls): Number of People With Depressive Disorder in People With and Without Ulcerative Colitis1,627 of 11,454

5,676 of 45,816

1.8 points

1.1 to 2.5

57,270NCT03836612

Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease

People With Ulcerative Colitis (Cases) vs People Without Ulcerative Colitis (Controls): Prevalence of Depressive Episodes (Ulcerative Colitis)507 of 11,454

1,666 of 45,816

0.8 points

0.4 to 1.2

57,270NCT03836612

Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease

People With Ulcerative Colitis (Cases) vs People Without Ulcerative Colitis (Controls): Prevalence of Anxiety Episodes (Ulcerative Colitis)341 of 11,454

1,221 of 45,816

0.3 points

-0.0 to 0.7

57,270NCT03836612

Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease

Anesthesia Control Tower Monitoring vs Standard of Care Arm: Fresh Gas Flow Rates19,839 of 26,837

19,899 of 26,739

-0.5 points

-1.2 to 0.2

53,576NCT03923699

Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety

LDCT Screening vs CXR Screening: Lung Cancer Diagnoses1,060 of 26,722

941 of 26,732

0.4 points

0.1 to 0.8

53,454NCT00047385

National Lung Screening Trial (NLST) Screening

LDCT Screening vs CXR Screening: Deaths From All Causes in All Randomized Participants.1,877 of 26,722

2,000 of 26,732

-0.5 points

-0.9 to -0.0

53,454NCT00047385

National Lung Screening Trial (NLST) Screening

LDCT Screening vs CXR Screening: Lung Cancer Deaths356 of 26,722

443 of 26,732

-0.3 points

-0.5 to -0.1

53,454NCT00047385

National Lung Screening Trial (NLST) Screening

Low-Dose CT vs Chest X-ray: serious adverse events0 of 26,722

2 of 26,732

-0.0 points

-0.0 to 0.0

53,454NCT00047385

National Lung Screening Trial (NLST) Screening

Type 1 Diabetes vs Type 2 Diabetes: serious adverse events130 of 13,529

80 of 37,641

0.7 points

0.6 to 0.9

51,170NCT00659295

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Oxygen Use Cohort vs No Oxygen Use Cohort: Number of Participants With Disease Progression From Pre-index Forced Vital Capacity (FVC) Result to Index Date162 of 24,680

110 of 24,680

0.2 points

0.1 to 0.3

49,360NCT05957198

Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

Oxygen Use Cohort vs No Oxygen Use Cohort: Number of Participants With Disease Progression From Index Date to Follow-up Forced Vital Capacity (FVC) Result575 of 24,680

456 of 24,680

0.5 points

0.2 to 0.7

49,360NCT05957198

Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

Intervention Arm vs Control Arm: Percentage of Patients With Well-controlled Blood Pressure16,910 of 24,747

16,441 of 24,463

1.1 points

0.3 to 1.9

49,210NCT05030467

Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension

Intervention vs Control: deaths from any cause493 of 23,546

483 of 23,787

0.1 points

-0.2 to 0.3

47,333NCT03259373

IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation

Intervention vs Control: serious adverse events737 of 23,546

760 of 23,787

-0.1 points

-0.4 to 0.3

47,333NCT03259373

IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation

Caring Contact Letters vs Caring Contact Control: serious adverse events1,177 of 22,380

1,071 of 22,775

0.6 points

0.2 to 1.0

45,155NCT05579600

Suicide Prevention for Criminal Legal Involved Managed Care Subscribers

Text-Messaging (TM) vs Text-Messaging Plus Patient Navigation (TM+PN): Reach-TM Engage2,594 of 22,145

2,401 of 22,584

1.1 points

0.5 to 1.7

44,729NCT04939532

SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers

Cases vs Controls: Number of Participants Having History of an Allergic Condition With Diagnosis of Venous Thromboembolism After the Start of Follow-up for Each Person193 of 18,742

203 of 25,088

0.2 points

0.0 to 0.4

43,830NCT04969653

The Incidence of Venous Thromboembolism in Atopic Dermatitis

Double-blind Phase: Ad26.COV2.S 5*10^10 vp vs Double-blind Phase: Placebo: Number of Participants With First Occurrence of Molecularly Confirmed, Moderate to Severe/Critical COVID-19 for Seronegative Participants (Double Blind Phase)575 of 21,898

1,189 of 21,890

-2.8 points

-3.2 to -2.4

43,788NCT04505722

A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=10

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03923699-fd2d7938",
        "title": "Anesthesia Control Tower Monitoring vs Standard of Care Arm: Measured Anesthetic Concentration",
        "summary": "30087 of 30460 against 29851 of 30175; risk difference -0.2 points, 95% interval -0.3 to 0.0; NCT03923699, Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety",
        "record": "/library/comparisons/NCT03923699-fd2d7938",
        "nct_id": "NCT03923699",
        "kind": "outcome",
        "participants": 60635,
        "risk_difference": {
          "value": -0.0015082025892950712,
          "lower": -0.00321105785179691,
          "upper": 0.00019049754577488403
        },
        "group_1": "30,087 of 30,460",
        "group_2": "29,851 of 30,175",
        "difference": "-0.2 points",
        "interval": "-0.3 to 0.0",
        "trial_title": "Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety"
      },
      {
        "id": "NCT04969653-2edb4875",
        "title": "Cases vs Controls: Number of Participants BMI ≥30 With Diagnosis of Venous Thromboembolism After the Start of Follow-up for Each Person",
        "summary": "685 of 23725 against 760 of 36835; risk difference 0.8 points, 95% interval 0.6 to 1.1; NCT04969653, The Incidence of Venous Thromboembolism in Atopic Dermatitis",
        "record": "/library/comparisons/NCT04969653-2edb4875",
        "nct_id": "NCT04969653",
        "kind": "outcome",
        "participants": 60560,
        "risk_difference": {
          "value": 0.008239946802325124,
          "lower": 0.005693780462501227,
          "upper": 0.010855851184297296
        },
        "group_1": "685 of 23,725",
        "group_2": "760 of 36,835",
        "difference": "0.8 points",
        "interval": "0.6 to 1.1",
        "trial_title": "The Incidence of Venous Thromboembolism in Atopic Dermatitis"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=11",
  "request_id": "suqXsHXO1uWQLlCn"
}
trial-comparisons-2026-03-23-0.1.0Next page

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?